Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP
Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP

Fosun Pharma stock surges on prospect of Covid-19 vaccine launch in China, after German partner BioNTech’s clinical success

  • ‘A victory for science, a victory for global cooperation,’ says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International
  • Fosun Pharma has a deal with Hong Kong-listed pharmaceutical distributor Jacobson Pharma for potentially supplying 10 million doses to Hong Kong and Macau

Topic |   Coronavirus Hong Kong
Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP
Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP
READ FULL ARTICLE